Home/Filings/4/0001235802-24-000028
4//SEC Filing

Schallenberger Mark A. 4

Accession 0001235802-24-000028

CIK 0001453593other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 4:23 PM ET

Size

5.8 KB

Accession

0001235802-24-000028

Insider Transaction Report

Form 4
Period: 2024-04-03
Schallenberger Mark A.
Chief Operations Officer
Transactions
  • Award

    Common Stock

    2024-04-03+177,551382,695 total
Footnotes (2)
  • [F1]These shares will vest and be issued with respect to 44,388 shares on each of April 3, 2025, April 3, 2026, and April 3, 2027 and with respect to 44,387 shares on April 3, 2028 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.
  • [F2]Includes an aggregate of 293,695 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 66,750 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting dates.

Issuer

Xtant Medical Holdings, Inc.

CIK 0001453593

Entity typeother

Related Parties

1
  • filerCIK 0001960742

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:23 PM ET
Size
5.8 KB